Ensuring Seniors' Access to Quality Care Act This bill repeals certain restrictions under Medicare and Medicaid that prohibit the approval of nurse-aide training and competency evaluation programs in skilled nursing facilities that have been subject to specified regulatory actions (e.g., civil penalties) for substandard quality of care. The Centers for Medicare & Medicaid Services (CMS) must still disapprove such programs for up to two years; however, the CMS must rescind the disapproval upon completion of corrective action and may require additional oversight of the program for purposes of rescission. The bill also allows Medicaid and Medicare providers (e.g., skilled nursing facilities) to access, through the National Practitioner Data Bank, disciplinary information for affiliated physicians and other health care practitioners, as reported by state licensing authorities.
This act extends the authorities of Title VII of the Foreign Intelligence Surveillance Act (FISA) until June 12, 2026. Title VII of FISA generally addresses electronic surveillance and other methods of acquiring foreign intelligence information that are directed at targets outside the United States. Title VII includes surveillance under Section 702, which concerns acquiring communications of non-U.S. persons believed to be outside the United States to obtain foreign intelligence information. Information about U.S. persons may incidentally be acquired by this type of surveillance and subsequently queried (searched) under certain circumstances. For additional information see CRS In Focus, IF11451 Foreign Intelligence Surveillance Act (FISA) ; and CRS Report, R48592 FISA Section 702 and the 2024 Reforming Intelligence and Securing America Act .
This bill, titled the Stop Subsidizing Private Jets of 2026, prevents taxpayers from deducting expenses related to private fixed-wing aircraft on their federal income tax returns. It directly affects individuals and businesses that purchase, maintain, or operate personal planes, effectively removing the tax benefit previously available for these costs. The law allows deductions only for specific exceptions, such as aircraft used for property transport, agriculture, firefighting, emergency medical services, or commercial activities like flight instruction and sightseeing tours. These changes will apply to any expenses incurred after December 31, 2025.
Logan's Law directs the Attorney General to create a free, public database listing individuals with qualifying violent convictions, requiring states that receive federal crime grants to submit their records. The database will allow searches by various personal details and conviction specifics, such as the judge and prosecutor involved, and must be updated at least every three months. Additionally, the bill requires the Attorney General to report on current barriers to sharing criminal records between states and the federal government and to propose solutions for improving this data exchange. States that fail to submit the required data could face penalties, including the withholding of federal Byrne JAG grant funds or the direct distribution of those funds to local governments within the state.
The Sudan Waiver Report Reduction Act modifies a reporting requirement within the Sudan Accountability and Divestment Act of 2007. It mandates that the head of the relevant executive agency must submit a written report to congressional committees within 30 days after the President grants a waiver under that law. This provision directly affects the President, executive agencies responsible for issuing waivers, and members of Congress who receive these reports. The bill does not change the criteria for granting waivers but instead establishes a specific timeline for documenting those decisions.
The FAIR Labels Act of 2026 establishes new labeling requirements for cell-cultivated protein products and plant-based alternatives designed to look like meat or poultry. It mandates that labels for these products prominently display the terms "cell-cultivated" or "plant-based alternative protein product" and include clear disclaimers stating the items are not derived from live animals or birds. Additionally, the bill updates regulatory oversight by requiring the USDA and FDA to revise their agreement, assigning the USDA primary responsibility for regulating cell-cultivated meat and poultry while the FDA oversees production safety and facility compliance. The legislation also directs these agencies to create common standards of identity for these products within 180 days of enactment.
The No WAR Act prohibits Congress from using budget reconciliation procedures to fund military hostilities against Iran unless such actions are explicitly authorized by a formal declaration of war or a specific authorization for the use of military force. This legislation directly affects the legislative process by establishing a point of order that blocks any reconciliation bill attempting to provide budget authority for offensive military operations, strikes, or covert actions targeting Iranian military forces, territory, or government institutions. The bill also defines proxy forces as any foreign military or irregular groups operating with U.S. direction or material support, ensuring these entities are included in the restrictions on unauthorized funding. By amending the Congressional Budget and Impoundment Control Act, the measure aims to prevent the use of budgetary shortcuts to bypass the constitutional requirement for congressional approval before engaging in armed conflict with Iran.
This joint resolution directs the President to remove United States Armed Forces from hostilities within or against Iran that have not been authorized by Congress. It states that Congress has not declared war or provided specific authorization for these military actions, citing the War Powers Resolution's 60-day limit for such operations. The bill mandates the withdrawal of forces unless Congress explicitly declares war or passes a specific authorization for military force against Iran. However, it clarifies that this directive does not prevent the U.S. from defending itself, sharing intelligence, assisting allies with defensive measures, or evacuating U.S. citizens.
SJRES 112 is a joint resolution seeking congressional disapproval of a Department of Commerce rule that would have suspended for one year the expansion of export controls on affiliates of certain entities already subject to U.S. restrictions. The rule, published in November 2025, aimed to delay stricter requirements for companies linked to designated entities under national security export regulations. If passed, this resolution would nullify the rule, requiring the expanded controls to take effect immediately instead of being paused. This directly affects businesses operating as affiliates of entities listed in U.S. export control programs.
This Senate resolution formally recognizes the week of May 3 through May 9, 2026, as National Small Business Week to honor the contributions of small business owners and entrepreneurs across the United States. The measure expresses appreciation for the economic role these businesses play and acknowledges the resilience of their owners and employees. By adopting this designation, the Senate aims to celebrate the entrepreneurial spirit within every community without imposing any new laws or regulations.
This resolution directs the House Committee on Oversight and Government Reform to take legal action in federal court to enforce a subpoena issued to Attorney General Pamela Bondi. The specific goal is to obtain a court order requiring Bondi to provide deposition testimony and documents related to the government's handling of sex trafficking cases and the Jeffrey Epstein investigation. The House Office of General Counsel is authorized to represent the committee in these proceedings and may hire additional private lawyers to assist. If the committee initiates or intervenes in the lawsuit, it must report its actions to the full House of Representatives as soon as possible.
Clinical Trial Modernization Act This bill authorizes a grant program and provides certain exemptions to support the participation of individuals in clinical trials. Specifically, the bill authorizes a grant program to support outreach, education, and recruitment efforts for clinical trials that may benefit certain underrepresented populations or communities in need, such as rural or tribal areas. The bill also exempts from anti-kickback laws for federal health care programs (1) remuneration that is offered to cover participants' expenses to participate in clinical trials, (2) the provision of free digital health technologies to support participation of underrepresented populations in clinical trials, and (3) payment for participants' cost-sharing obligations in relation to clinical trials. Finally, the bill exempts up to $2,000 in remuneration that is received for participating in a clinical trial from income tax.
